Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Patients With Acute Lymphoblastic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002912
What this trial is testing

Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00042341
What this trial is testing

Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Lymphoblastic, Acute, Pediatric
Genzyme, a Sanofi Company 60
Not applicableStudy completedNCT01556386
What this trial is testing

Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Seoul National University Hospital 200
Testing effectiveness (Phase 2)UnknownNCT05252403
What this trial is testing

Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 35
Testing effectiveness (Phase 2)WithdrawnNCT05320380
What this trial is testing

The Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute Leukemia+5 more
Children's Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT04094311
What this trial is testing

Study of Out of Specification for Tisagenlecleucel

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 200
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Ended earlyNCT04225676
What this trial is testing

Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 5
Large-scale testing (Phase 3)Study completedNCT00005585
What this trial is testing

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 838
Not applicableStudy completedNCT02007863
What this trial is testing

Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia

Who this might be right for
LeukemiaMyelodysplasiaAcute Lymphocytic Leukemia+1 more
University of Miami 2
Early research (Phase 1)Study completedNCT01523977
What this trial is testing

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Study completedNCT04956666
What this trial is testing

A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Institut de Recherches Internationales Servier 75
Testing effectiveness (Phase 2)Looking for participantsNCT05751044
What this trial is testing

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Testing effectiveness (Phase 2)Study completedNCT00930098
What this trial is testing

A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukemia
Genzyme, a Sanofi Company 74
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Not applicableStudy completedNCT01156883
What this trial is testing

Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 76
Early research (Phase 1)Looking for participantsNCT05476770
What this trial is testing

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAMLALL+8 more
Therapeutic Advances in Childhood Leukemia Consortium 54
Early research (Phase 1)Study completedNCT00022451
What this trial is testing

Tipifarnib in Treating Young Patients With Refractory Leukemia

Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Next Page
26